Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
PHASE3
The primary objective of the study was to evaluate whether progression-free...
Status
Terminated
Location
University of Alabama at Birmingham - Main /ID# 138087
Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung Cancer
PHASE1
The study seeks to assess the efficacy of veliparib (ABT-888) in combinatio...
A Study Evaluating the Efficacy and Tolerability of Veliparib in Combination With Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Veliparib and Paclitaxel/Carboplatin Consolidation in Adults With Stage III Non-Small Cell Lung Cancer (NSCLC)
PHASE1
This study seeks to establish
* the recommended Phase 2 dose (RPTD) of vel...
A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast Cancer
PHASE3
This is a 3 arm Phase 3 study to evaluate the safety and efficacy of the ad...
Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide (TMZ) or In Combination With Carboplatin and Paclitaxel Versus Placebo in Participants With Breast Cancer Gene (BRCA)1 and BRCA2 Mutation and Metastatic Breast Cancer
PHASE2
The primary objective of the study is to assess the progression-free surviv...
Status
Completed
Location
University of Alabama at Birmingham - Main /ID# 62994
Comparison of Veliparib and Whole Brain Radiation Therapy (WBRT) Versus Placebo and WBRT in Adults With Brain Metastases From Non-Small Cell Lung Cancer
PHASE2
The primary objective of this study is to evaluate the efficacy and safety ...
A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer
PHASE3
The primary objective of the study is to assess the progression-free surviv...